ATA100695A - Prothrombin-derivate - Google Patents

Prothrombin-derivate

Info

Publication number
ATA100695A
ATA100695A AT0100695A AT100695A ATA100695A AT A100695 A ATA100695 A AT A100695A AT 0100695 A AT0100695 A AT 0100695A AT 100695 A AT100695 A AT 100695A AT A100695 A ATA100695 A AT A100695A
Authority
AT
Austria
Prior art keywords
prothromine
derivatives
prothromine derivatives
Prior art date
Application number
AT0100695A
Other languages
English (en)
Other versions
AT404357B (de
Inventor
Bernhard Fischer
Uwe Schlokat
Artur Mitterer
Falko-Guenter Falkner
Johann Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0100695A priority Critical patent/AT404357B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to HU9900506A priority patent/HUP9900506A3/hu
Priority to PCT/AT1996/000105 priority patent/WO1996041868A2/de
Priority to EP96915903A priority patent/EP0833897A2/de
Priority to US08/952,967 priority patent/US6086871A/en
Priority to CZ974020A priority patent/CZ402097A3/cs
Priority to JP9502398A priority patent/JPH11507542A/ja
Priority to CA002224634A priority patent/CA2224634A1/en
Priority to AU58871/96A priority patent/AU700631B2/en
Priority to AT180596A priority patent/AT404516B/de
Publication of ATA100695A publication Critical patent/ATA100695A/de
Application granted granted Critical
Publication of AT404357B publication Critical patent/AT404357B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT0100695A 1995-06-13 1995-06-13 Prothrombin-derivate AT404357B (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AT0100695A AT404357B (de) 1995-06-13 1995-06-13 Prothrombin-derivate
PCT/AT1996/000105 WO1996041868A2 (de) 1995-06-13 1996-06-12 Prothrombin-derivate
EP96915903A EP0833897A2 (de) 1995-06-13 1996-06-12 Prothrombin-derivate
US08/952,967 US6086871A (en) 1995-06-13 1996-06-12 Prothrombin derivatives
HU9900506A HUP9900506A3 (en) 1995-06-13 1996-06-12 Prothrombin derivatives
CZ974020A CZ402097A3 (cs) 1995-06-13 1996-06-12 Deriváty prothrombinu
JP9502398A JPH11507542A (ja) 1995-06-13 1996-06-12 プロトロンビン誘導体
CA002224634A CA2224634A1 (en) 1995-06-13 1996-06-12 Prothrombin derivatives
AU58871/96A AU700631B2 (en) 1995-06-13 1996-06-12 Prothrombin derivatives
AT180596A AT404516B (de) 1995-06-13 1996-10-14 Vorrichtung zur quantifizierung von prothrombin-derivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0100695A AT404357B (de) 1995-06-13 1995-06-13 Prothrombin-derivate

Publications (2)

Publication Number Publication Date
ATA100695A true ATA100695A (de) 1998-03-15
AT404357B AT404357B (de) 1998-11-25

Family

ID=3504770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0100695A AT404357B (de) 1995-06-13 1995-06-13 Prothrombin-derivate

Country Status (9)

Country Link
US (1) US6086871A (de)
EP (1) EP0833897A2 (de)
JP (1) JPH11507542A (de)
AT (1) AT404357B (de)
AU (1) AU700631B2 (de)
CA (1) CA2224634A1 (de)
CZ (1) CZ402097A3 (de)
HU (1) HUP9900506A3 (de)
WO (1) WO1996041868A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231210D1 (de) * 2001-07-06 2009-04-02 Chemo Sero Therapeut Res Inst Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik
AU2008202376B2 (en) * 2001-07-06 2011-02-10 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing human thrombin by gene modification technique
US20030099957A1 (en) * 2001-09-28 2003-05-29 Vitivity, Inc. Diagnosis and treatment of vascular disease
WO2006104398A1 (en) * 2005-03-26 2006-10-05 Protemix Corporation Limited Copper antagonist compositions
CN101535479A (zh) 2006-11-15 2009-09-16 智索株式会社 凝血酶突变体
BRPI0816837B1 (pt) * 2007-09-28 2022-10-18 Portola Pharmaceuticals, Inc Composições farmacêuticas, polipeptídeo isolado de duas cadeias e uso de uma composição farmacêutica
US8466106B2 (en) * 2008-10-27 2013-06-18 Trustees Of Tufts College Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
US8455439B2 (en) 2008-11-14 2013-06-04 Portola Pharmaceuticals, Inc. Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents
PT3604510T (pt) 2009-03-30 2025-06-24 Alexion Pharma Inc Antídotos para inibidores do fator xa e métodos de utilização dos mesmos
PT2453910T (pt) * 2009-07-15 2016-12-07 Portola Pharm Inc Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
AR079944A1 (es) 2010-01-20 2012-02-29 Boehringer Ingelheim Int Anticuerpo neutralizante de la actividad de un anticoagulante
EP2471945A1 (de) * 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung von Inhibitoren der Gerinnung
WO2012130834A1 (en) 2011-03-30 2012-10-04 Boehringer Ingelheim International Gmbh Anticoagulant antidotes
AU2013248727A1 (en) * 2012-04-17 2014-11-06 Aarhus Universitet SorCS1 for use in the treatment of obesity and overweight
GB2504499A (en) * 2012-07-31 2014-02-05 Baxter Healthcare Sa Selective measurement of active human protease coagulation factors
EP3744840A1 (de) 2014-05-26 2020-12-02 Academisch Ziekenhuis Leiden Prohämostatische proteine zur behandlung von blutungen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
DK0380443T4 (da) * 1989-01-25 1999-11-29 Novartis Ag Monoklonale antistoffer specifikke for hirudin
CA2073859A1 (en) * 1990-01-26 1991-07-27 Falko-Guenter Falkner Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
US6110721A (en) * 1993-11-12 2000-08-29 Gilead Sciences, Inc. Polypeptides and coagulation therapy
AT401270B (de) * 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna

Also Published As

Publication number Publication date
HUP9900506A3 (en) 2001-10-29
CA2224634A1 (en) 1996-12-27
WO1996041868A2 (de) 1996-12-27
JPH11507542A (ja) 1999-07-06
WO1996041868A3 (de) 1997-04-10
HUP9900506A2 (hu) 1999-06-28
EP0833897A2 (de) 1998-04-08
AU5887196A (en) 1997-01-09
US6086871A (en) 2000-07-11
AU700631B2 (en) 1999-01-07
CZ402097A3 (cs) 1998-04-15
AT404357B (de) 1998-11-25

Similar Documents

Publication Publication Date Title
DE69522717D1 (de) Chinazolinderivate
DE69611361D1 (de) Chinazolin-derivate
NO974103D0 (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
DE69612617D1 (de) Chloridunterstützte hydrometallurgische metallextraktion
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
NO964667D0 (no) Purin-6-on-derivater
DE69524382D1 (de) Spiralverdrängermaschine
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
DE69627830D1 (de) Pyrazol-derivate
DE69628200D1 (de) Diarylalkenylamin-derivate
NO961404D0 (no) 4-indolylpiperazinyl-derivater
DK0723963T3 (da) 4-Amino-benzoylguanidin-derivater
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE225347T1 (de) Aza-anthracyclinone-derivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate
DE69608334D1 (de) Cycloalkenyltetrazolinone
DE69620514D1 (de) 5-aminoflavon-derivate
ATA45796A (de) Lysin-prolin-derivate

Legal Events

Date Code Title Description
MK07 Expiry

Effective date: 20150613